We are live on ! Find out more
ANGO icon

AngioDynamics

170 hedge funds and large institutions have $941M invested in AngioDynamics in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 67 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 13

9% more funds holding

Funds holding: 156170 (+14)

4% more capital invested

Capital invested by funds: $902M → $941M (+$39.3M)

0.46% more ownership

Funds ownership: 93.47%93.93% (+0.46%)

22% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 67

55% less call options, than puts

Call options by funds: $242K | Put options by funds: $543K

Holders
170
Holders Change
+14
Holders Change %
+8.97%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
52
Reduced
67
Closed
13
Calls
$242K
Puts
$543K
Net Calls
-$301K
Net Calls Change
+$1.55M

ANGO Hedge Fund Activity: Q4 2021 in Review

170 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2021, worth a combined $941M — up 4.4% from $902M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ANGO positions and 13 closed out — a net gain of 16 holders — while 52 added to existing stakes and 67 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $11.6M. The largest seller was Bank of Montreal, cutting an estimated $15.7M.

  • 170 institutional investors held AngioDynamics (ANGO) as of Q4 2021, up from 156 in Q3 2021.
  • Funds reported $941M of AngioDynamics stock for Q4 2021, up 4.4% quarter-over-quarter.
  • 29 funds opened new AngioDynamics positions in Q4 2021 and 13 closed out, a net change of +16 holders.
  • The largest AngioDynamics buyer in Q4 2021 was Point72 Asset Management, an estimated $11.6M added.
  • The largest AngioDynamics seller in Q4 2021 was Bank of Montreal, an estimated $15.7M sold.

Based on aggregated 13F filings for Q4 2021.